Pre-Open Stock Movers 06/26: (MDCA) (VXRT) (GPS) Higher; (SHIP) (SOLY) (NKE) Lower (more...)
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/19/2026
Go back to Pre-Open Stock Movers 06/26: (MDCA) (VXRT) (GPS) Higher; (SHIP) (SOLY) (NKE) Lower (more...)
June 30, 2020 7:26 AM EDT
Argus analyst John Staszak reiterated a Buy rating and $115.00 price target on Nike (NYSE: NKE) following the company's 4Q earnings report. Nike reported fiscal 4Q20 revenue and EPS that missed estimates. Revenue of $6.3 billion. the consensus estimate had called for revenue of $7.3 billion. The adjusted... More
June 30, 2020 7:04 AM EDT
Altimmune, Inc. (NASDAQ: ALT) today announced dosing of the first patient in the Companys Phase 1b clinical trial of NasoShield, a single dose intranasal anthrax vaccine candidate. The NasoShield program is being developed under a contract with the Biomedical Advanced Research and Development Authority (BARDA), with a total potential value of $133.7 million if all options in the contract (HHSO100201600008C) are exercised.
NasoShield is the only single dose anthrax vaccine in development that is supported by BARDA, and has the potential to provide a significant improvement over the available two- and... More
